Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
about
Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosisAbaloparatideParathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation.Dose-dependence of PTH-related peptide-1 on the osteogenic induction of MC3T3-E1 cells in vitro.Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trialsIntermittent PTHrP(1-34) exposure augments chondrogenesis and reduces hypertrophy of mesenchymal stromal cells.Conditional disruption of miR17-92 cluster in collagen type I-producing osteoblasts results in reduced periosteal bone formation and bone anabolic response to exercise.Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.The effect of bovine parathyroid hormone withdrawal on MC3T3-E1 cell proliferation and phosphorus metabolism.Long term effects on mineral and bone metabolism by low versus standard calcium dialysate in peritoneal dialysis: a meta-analysis.The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide-mediated vasorelaxation in BALB/c mice.The Role of Parathyroid Hormone-Related Protein (PTHrP) in Osteoblast Response to Microgravity: Mechanistic Implications for Osteoporosis Development.PTH Signaling During Exercise Contributes to Bone Adaptation.MicroRNAs and Bone Regeneration.The Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM).Deregulation of bone forming cells in bone diseases and anabolic effects of strontium-containing agents and biomaterials.The dual face of parathyroid hormone and prostaglandins in the osteoimmune system.Current status of drug therapies for osteoporosis and the search for stem cells adapted for bone regenerative medicine.The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab.Structure of Class B GPCRs: new horizons for drug discovery.A Woman with Rheumatoid Arthritis and a Bilateral Fracture of the Proximal Tibia.Parathyroid Hormone-Related Protein Protects Osteoblastic Cells From Oxidative Stress by Activation of MKP1 Phosphatase.Mitogen-activated protein kinase phosphatase-1: function and regulation in bone and related tissues.PTH and Vitamin D.Role of the Parathyroid Hormone Type 1 Receptor (PTH1R) as a Mechanosensor in Osteocyte Survival.Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor SignalsFunctional roles of the nuclear localization signal of parathyroid hormone-related protein (PTHrP) in osteoblastic cells.PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains.Local delivery of parathyroid hormone-related protein-derived peptides coated onto a hydroxyapatite-based implant enhances bone regeneration in old and diabetic rats.Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1-17.Osteogenic Effect of ZnO-Mesoporous Glasses Loaded with Osteostatin
P2860
Q27024513-38E0935D-D050-4A72-B43D-497AF3384A4EQ28073605-83B2B166-07BA-46C9-A474-88F6C73E12B9Q30580472-D17D72E5-FC55-4AED-883D-9DD32ADBF695Q33627058-833F2477-D897-4F3C-9B51-B52594CD0453Q33758618-C1FEAAF1-0204-422D-85AC-09373C558BDFQ34294193-BD463049-C9AD-4C66-AD6D-E682A902ED35Q35035478-D23605C2-4F77-46CE-BCBE-4CF96440A102Q35087758-7582B697-5394-4267-B786-AD687361095CQ35182148-4FAD22FD-F853-4CA3-A9DB-021819260582Q35479821-CB0FAFE5-ED9C-4369-8A20-1C9FCB3EE254Q35911537-03BD3555-DE40-41C0-A6CF-2CF8357C0C57Q36087241-6F8DBCCD-67EB-43CC-94B2-5948C938B7D7Q36525466-EE8B8E9B-58B3-49FC-9244-18C6B8BFC744Q36613082-E247418D-08E0-4563-B6BD-998067F1E82BQ37629885-7E31CDD7-9F65-4ADC-8716-00FE48B9B73CQ37706364-353DE4E7-884F-46C2-A7A6-402FCCC8F1AAQ38138832-E730FD90-46C6-4D4D-B903-47B793502F46Q38156028-280714B2-15BA-4C83-9217-4AC65925987AQ38193181-7383795D-BC12-4DA8-A13C-778C77A76762Q38195892-E87C8CBB-B563-4C83-8F5E-F170A433D328Q38621377-BBFE5986-A9A6-4A13-8EDE-B1CD1D5872E5Q38760873-6048D7AD-AA7E-4E95-8FE1-E4593971803DQ38794453-5097087C-6624-40A4-9718-2F18A5086337Q38804461-0291FA52-BF21-4E34-AE36-C8A7002017DAQ38926507-CF8D15A3-AD06-4E49-B7EC-F76AC964FD94Q38991169-A7D0F613-8E9C-4242-A9F8-730375DF2870Q42005257-0562BEF6-8546-4835-A671-E1BB10B99500Q48038374-E082DC80-2A31-4965-99F5-6D7F054931FEQ50058849-01625FF5-6B06-46FE-8CD3-30A7F2098BF8Q50244063-A738D20C-D919-49F2-AD5F-7875E53018EDQ51075730-E35D6DA2-5E23-4494-9D79-9C225E9A8704Q58800457-6AF5156A-A368-4B93-A6EB-AA59B6CE4995
P2860
Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current perspectives on parath ...... P) as bone anabolic therapies.
@en
type
label
Current perspectives on parath ...... P) as bone anabolic therapies.
@en
prefLabel
Current perspectives on parath ...... P) as bone anabolic therapies.
@en
P1476
Current perspectives on parath ...... P) as bone anabolic therapies.
@en
P2093
María José Alcaraz
Pedro Esbrit
P304
P356
10.1016/J.BCP.2013.03.002
P407
P577
2013-03-13T00:00:00Z